Comprehensive Metabolic Panel Testing Market - By Test Type (Glucose, Calcium, Electrolytes, Kidney Function Tests, Liver Function Tests, Proteins), By Disease Indication (Kidney Diseases)

Description

List of Tables

Comprehensive metabolic panel testing market size is projected to expand at 8.7% CAGR from 2023 to 2032, driven by the increasing prevalence of chronic diseases, rising aging population, and the greater need for early detection and monitoring of metabolic disorders.

The growing awareness of preventive healthcare and the increasing advancements in diagnostic technologies is driving the integration of comprehensive metabolic panels in routine health check-up. For instance, in January 2022, Quest Diagnostics introduced a Virtual Preventive Care Service via QuestDirect™ for empowering individuals to proactively manage their health and well-being. The surging demand for personalized medicine and the higher adoption of point-of-care testing will further amplify the market growth to meet the evolving healthcare needs of the diverse patient population.

The comprehensive metabolic panel testing industry is segregated into test type, disease indication, end-use, and region.

Based on test type, the market share from the kidney function tests segment is projected to exhibit 8.6% CAGR through 2032, attributed to the increasing prevalence of renal disorders. The rising aging population, and the critical role of kidney function tests in assessing and monitoring kidney health will boost the segment growth.

The liver disease indication segment is projected to capture sizeable share of the comprehensive metabolic panel testing market, recording 8.5% CAGR from 2023 to2032. The increasing prevalence of liver disorders is prompting the growing need for early detection. The crucial role of metabolic panels in assessing liver function will also fuel the segment expansion.

In terms of end-use, the market value form the hospitals segment is estimated to withhold 8.5% CAGR during 2023-2032. This is driven by the high patient volume in hospitals along with the growing need for rapid diagnostic services. Moreover, the routine incorporation of metabolic panels in comprehensive healthcare assessments will fuel the testing demand in hospital settings.

Regionally, the Asia Pacific comprehensive metabolic panel testing industry is slated to expand at robust rate through 2032, led by the increasing prevalence of metabolic disorders along with growing healthcare infrastructure. The rising preference for routine health check-ups and the increasing advancements in diagnostic technologies will further boost the regional market growth.

Product Code: 7156

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global comprehensive metabolic panel testing market 360 degree synopsis, 2018 - 2032
2.2 Regional trends
2.3 Test type trends
2.4 Disease indication trends
2.5 End-use trends

Chapter 3 Comprehensive Metabolic Panel Testing Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Increasing prevalence of diabetes
  - 3.5.1.2 Technological advancements in comprehensive metabolic panel testing
  - 3.5.1.3 Growing awareness regarding early diagnosis and treatment of diseases
  - 3.5.1.4 Growing inclination towards usage of point of care devices
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 Lack of reimbursement scenario
  - 3.5.2.2 Stringent regulatory scenario
3.6 Growth potential analysis
- 3.6.1 By test type
- 3.6.2 By disease indication
- 3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 Abbott Laboratories
- 4.1.2 Quest Diagnostics
- 4.1.3 Laboratory Corporation of America Holdings Limited
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022

Chapter 5 Comprehensive Metabolic Panel Testing Market Size and Forecast, By Test Type, 2018-2032 (USD Million)

5.1 Key trends, by test type
5.2 Glucose
5.3 Calcium
5.4 Electrolytes
- 5.4.1 Sodium
- 5.4.2 Potassium
- 5.4.3 Other electrolytes
5.5 Kidney function tests
- 5.5.1 Blood urea nitrogen (BUN)
- 5.5.2 Creatinine
5.6 Liver function tests
- 5.6.1 Albumin
- 5.6.2 Bilirubin
- 5.6.3 Alkaline phosphatase
- 5.6.4 Aspartate aminotransferase (AST)
- 5.6.5 Alanine aminotransferase (ALT)
5.7 Proteins

Chapter 6 Comprehensive Metabolic Panel Testing Market Size and Forecast, By Disease Indication, 2018-2032 (USD Million)

6.1 Key trends, by disease indication
6.2 Kidney diseases
6.3 Liver diseases
6.4 Diabetes
6.5 Other disease indications

Chapter 7 Comprehensive Metabolic Panel Testing Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1 Key trends, by end-use
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Point of care centers
7.5 Other end-users

Chapter 8 Comprehensive Metabolic Panel Testing Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Abbott Laboratories
9.2 Quest Diagnostics
9.3 Laboratory Corporation of America Holdings Limited
9.4 Sonic Healthcare
9.5 Unipath
9.6 SYNLAB International GmbH
9.7 ARUP Laboratories
9.8 Genoptix Inc.
9.9 Nova Medical
9.10 Charles River Laboratories Inc.
9.11 Scion Lab Services LLC
9.12 Walk-In Lab, LLC
9.13 CENTOGENE N.V.
9.14 Abaxis